4.7 Article

Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia

Journal

EUROPEAN JOURNAL OF CANCER
Volume 142, Issue -, Pages 10-17

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ejca.2020.10.013

Keywords

Melanoma brain; metastasis; Guidelines; Systemic therapy; Surgery; Radiation therapy

Categories

Funding

  1. Skin Cancer College Australasia
  2. Australasian College of Dermatologists

Ask authors/readers for more resources

The brain is a common site of metastatic disease for patients with advanced melanoma, with treatment approaches including surgery, radiotherapy, and systemic therapy. Management of melanoma brain metastases should involve a multidisciplinary team and consider optimal combinations and sequencing of treatments. It is important to establish appropriate guidelines for the management of melanoma brain metastases and update them regularly as new treatment options become available.
Introduction: The brain is a common site of metastatic disease for patients with advanced melanoma. Brain metastasis portends a poor prognosis, often causing deterioration in neurological function and quality of life, and leading to neurological death. Treatment approaches including surgery, radiotherapy and systemic therapy can lead to better control of this problem. Therefore, appropriate guidelines for the management of melanoma brain metastases need to be established, with regular updating when new treatment options become available. Methods: A multidisciplinary working party established by Cancer Council Australia has produced up-to-date, evidence-based clinical practice guidelines for the management of melanoma. After selecting key clinical questions, a comprehensive literature search for relevant studies was conducted, followed by systematic review of those studies. Data were summarised and the evidence was assessed, leading to the development of recommendations. Main recommendations: Symptomatic lesions are best treated with surgery, when possible; this provides safe and effective local control. For patients with single or a small number of asymptomatic brain metastases, stereotactic radiotherapy is recommended, but in asymptomatic patients who have not previously received systemic treatment, drug therapy can be considered as a first-line treatment option. Whole brain radiotherapy may provide palliative benefits in patients with multiple brain metastases. Whenever possible, melanoma patients with brain metastases should be managed by a multidisciplinary team of melanoma specialists that considers the optimal combination and sequencing of surgery, radiotherapy and systemic therapy. Crown Copyright (C) 2020 Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available